This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
KYTHERA Biopharmaceuticals (NASDAQ:KYTH) focuses on the discovery, development, and commercialization of prescription products for the aesthetic medicine market. KYTH also gets F’s in Earnings Growth, Earnings Momentum, and Equity. For more information, get Portfolio Grader’s complete analysis of KYTH stock.
Navidea Biopharmaceuticals, Inc. (AMEX:NAVB) is focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer. NAVB also gets F’s in Equity and Cash Flow. Since January 1, NAVB has fallen 17.2%. For more information, get Portfolio Grader’s complete analysis of NAVB stock.
City Telecom (H.K.) Ltd. (NASDAQ:CTEL) provides fixed telecommunications networks and international telecommunications services for residential and corporate customers. CTEL gets F’s in Earnings Growth and Operating Margin Growth as well. For more information, get Portfolio Grader’s complete analysis of CTEL stock.
Hong Kong Television Network Ltd. Sponsored ADR (NASDAQ:HKTV) engages in the provision of multimedia production and contents distribution business, and other multimedia related activities in Hong Kong. HKTV also gets F’s in Earnings Growth and Operating Margin Growth. For more information, get Portfolio Grader’s complete analysis of HKTV stock.
Neuralstem, Inc. (AMEX:CUR) is a biotherapeutics company utilizing its Human Neural Stem Cell technology to develop cures for diseases of the CNS. CUR gets F’s in Analyst Earnings Revisions, Equity, and Cash Flow as well. For more information, get Portfolio Grader’s complete analysis of CUR stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.